Exclusive deal : 20% Instant discount on Direct purchases! Don't wait—claim your discount today!
Nosocomial infection, also known as hospital acquired or associated infection (HAI) is defined as an infection developed in patients during the hospital stay that was earlier not present or incubated during admission in the hospital.
The latest research study released by Market IntelliX evaluates market size and forecasts of Nosocomial Infection Treatment in Global, including the following market information:
Global Nosocomial Infection Treatment Market Revenue, 2017-2022, 2023-2028, ($ millions)
Global top five companies in 2021 (%)
The global Nosocomial Infection Treatment market was valued at million in 2021 and is projected to reach US$ million by 2028, at a CAGR of % during the forecast period.
The U.S. Market is Estimated at $ Million in 2021, While China is Forecast to Reach $ Million by 2028.
Antibacterial Treatment Segment to Reach $ Million by 2028, with a % CAGR in next six years.
The global key manufacturers of Nosocomial Infection Treatment include Abbott, Bayer, Becton, Dickinson and Company, Belimed, BioMerieux, Cantel, Cepheid, Getinge Group and Kimberly-Clark Corp., etc. In 2021, the global top five players have a share approximately % in terms of revenue.
MI has surveyed the Nosocomial Infection Treatment companies, and industry experts on this industry, involving the revenue, demand, product type, recent developments and plans, industry trends, drivers, challenges, obstacles, and potential risks.
Market Segmentations:
Global Nosocomial Infection Treatment Market, by Type, 2017-2022, 2023-2028 ($ millions)
Global Nosocomial Infection Treatment Market Segment Percentages, by Type, 2021 (%)
Antibacterial Treatment
Antiviral Treatment
Antifungal Treatment
Global Nosocomial Infection Treatment Market, by Application, 2017-2022, 2023-2028 ($ millions)
Global Nosocomial Infection Treatment Market Segment Percentages, by Application, 2021 (%)
Ventilator Associated Pneumonia
Urinary Tract Infection
Blood Stream Infection
Surgical Site Infection
Gastrointestinal Infection
MRSA
Global Nosocomial Infection Treatment Market, By Region and Country, 2017-2022, 2023-2028 ($ Millions)
Global Nosocomial Infection Treatment Market Segment Percentages, By Region and Country, 2021 (%)
North America
US
Canada
Mexico
Europe
Germany
France
U.K.
Italy
Russia
Nordic Countries
Benelux
Rest of Europe
Asia
China
Japan
South Korea
Southeast Asia
India
Rest of Asia
South America
Brazil
Argentina
Rest of South America
Middle East & Africa
Turkey
Israel
Saudi Arabia
UAE
Rest of Middle East & Africa
Competitor Analysis
The report also provides analysis of leading market participants including:
Key companies Nosocomial Infection Treatment revenues in global market, 2017-2022 (estimated), ($ millions)
Key companies Nosocomial Infection Treatment revenues share in global market, 2021 (%)
The report presents profiles of competitors in the market, Some of the prominent key players covered:
Abbott
Bayer
Becton, Dickinson and Company
Belimed
BioMerieux
Cantel
Cepheid
Getinge Group
Kimberly-Clark Corp.
Merck & Co
Nordion
Pfizer
Roche
Sakura Seiki
BioMérieux
Steris
Johnson & Johnson
Sterigenics International, Inc.
Halyard Health, Inc.
Advanced Sterilization Products
Matachana Group
Key Takeaways from this Report
Evaluate market potential through analyzing growth rates (CAGR %), Volume (Units) and Value ($M) data given at country level – for product types, end use applications and by different industry verticals.
Understand the different dynamics influencing the market – key driving factors, challenges and hidden opportunities.
Get in-depth insights on your competitor performance – market shares, strategies, financial benchmarking, product benchmarking, SWOT and more.
Analyze the sales and distribution channels across key geographies to improve top-line revenues.
Understand the industry supply chain with a deep-dive on the value augmentation at each step, in order to optimize value and bring efficiencies in your processes.
Get a quick outlook on the market entropy – M&A’s, deals, partnerships, product launches of all key players for the past 4 years.
Evaluate the supply-demand gaps, import-export statistics and regulatory landscape for more than top 20 countries globally for the market.
1 Introduction to Research & Analysis Reports
1.1 Nosocomial Infection Treatment Market Definition
1.2 Market Segments
1.2.1 Market by Type
1.2.2 Market by Application
1.3 Global Nosocomial Infection Treatment Market Overview
1.4 Features & Benefits of This Report
1.5 Methodology & Sources of Information
1.5.1 Research Methodology
1.5.2 Research Process
1.5.3 Base Year
1.5.4 Report Assumptions & Caveats
2 Global Nosocomial Infection Treatment Overall Market Size
2.1 Global Nosocomial Infection Treatment Market Size: 2021 VS 2028
2.2 Global Nosocomial Infection Treatment Market Size, Prospects & Forecasts: 2017-2028
2.3 Key Market Trends, Opportunity, Drivers and Restraints
2.3.1 Market Opportunities & Trends
2.3.2 Market Drivers
2.3.3 Market Restraints
3 Company Landscape
3.1 Top Nosocomial Infection Treatment Players in Global Market
3.2 Top Global Nosocomial Infection Treatment Companies Ranked by Revenue
3.3 Global Nosocomial Infection Treatment Revenue by Companies
3.4 Top 3 and Top 5 Nosocomial Infection Treatment Companies in Global Market, by Revenue in 2021
3.5 Global Companies Nosocomial Infection Treatment Product Type
3.6 Tier 1, Tier 2 and Tier 3 Nosocomial Infection Treatment Players in Global Market
3.6.1 List of Global Tier 1 Nosocomial Infection Treatment Companies
3.6.2 List of Global Tier 2 and Tier 3 Nosocomial Infection Treatment Companies
4 Market Sights by Product
4.1 Overview
4.1.1 by Type - Global Nosocomial Infection Treatment Market Size Markets, 2021 & 2028
4.1.2 Antibacterial Treatment
4.1.3 Antiviral Treatment
4.1.4 Antifungal Treatment
4.2 By Type - Global Nosocomial Infection Treatment Revenue & Forecasts
4.2.1 By Type - Global Nosocomial Infection Treatment Revenue, 2017-2022
4.2.2 By Type - Global Nosocomial Infection Treatment Revenue, 2023-2028
4.2.3 By Type - Global Nosocomial Infection Treatment Revenue Market Share, 2017-2028
5 Sights by Application
5.1 Overview
5.1.1 By Application - Global Nosocomial Infection Treatment Market Size, 2021 & 2028
5.1.2 Ventilator Associated Pneumonia
5.1.3 Urinary Tract Infection
5.1.4 Blood Stream Infection
5.1.5 Surgical Site Infection
5.1.6 Gastrointestinal Infection
5.1.7 MRSA
5.2 By Application - Global Nosocomial Infection Treatment Revenue & Forecasts
5.2.1 By Application - Global Nosocomial Infection Treatment Revenue, 2017-2022
5.2.2 By Application - Global Nosocomial Infection Treatment Revenue, 2023-2028
5.2.3 By Application - Global Nosocomial Infection Treatment Revenue Market Share, 2017-2028
6 Sights by Region
6.1 By Region - Global Nosocomial Infection Treatment Market Size, 2021 & 2028
6.2 By Region - Global Nosocomial Infection Treatment Revenue & Forecasts
6.2.1 By Region - Global Nosocomial Infection Treatment Revenue, 2017-2022
6.2.2 By Region - Global Nosocomial Infection Treatment Revenue, 2023-2028
6.2.3 By Region - Global Nosocomial Infection Treatment Revenue Market Share, 2017-2028
6.3 North America
6.3.1 By Country - North America Nosocomial Infection Treatment Revenue, 2017-2028
6.3.2 US Nosocomial Infection Treatment Market Size, 2017-2028
6.3.3 Canada Nosocomial Infection Treatment Market Size, 2017-2028
6.3.4 Mexico Nosocomial Infection Treatment Market Size, 2017-2028
6.4 Europe
6.4.1 By Country - Europe Nosocomial Infection Treatment Revenue, 2017-2028
6.4.2 Germany Nosocomial Infection Treatment Market Size, 2017-2028
6.4.3 France Nosocomial Infection Treatment Market Size, 2017-2028
6.4.4 U.K. Nosocomial Infection Treatment Market Size, 2017-2028
6.4.5 Italy Nosocomial Infection Treatment Market Size, 2017-2028
6.4.6 Russia Nosocomial Infection Treatment Market Size, 2017-2028
6.4.7 Nordic Countries Nosocomial Infection Treatment Market Size, 2017-2028
6.4.8 Benelux Nosocomial Infection Treatment Market Size, 2017-2028
6.5 Asia
6.5.1 By Region - Asia Nosocomial Infection Treatment Revenue, 2017-2028
6.5.2 China Nosocomial Infection Treatment Market Size, 2017-2028
6.5.3 Japan Nosocomial Infection Treatment Market Size, 2017-2028
6.5.4 South Korea Nosocomial Infection Treatment Market Size, 2017-2028
6.5.5 Southeast Asia Nosocomial Infection Treatment Market Size, 2017-2028
6.5.6 India Nosocomial Infection Treatment Market Size, 2017-2028
6.6 South America
6.6.1 By Country - South America Nosocomial Infection Treatment Revenue, 2017-2028
6.6.2 Brazil Nosocomial Infection Treatment Market Size, 2017-2028
6.6.3 Argentina Nosocomial Infection Treatment Market Size, 2017-2028
6.7 Middle East & Africa
6.7.1 By Country - Middle East & Africa Nosocomial Infection Treatment Revenue, 2017-2028
6.7.2 Turkey Nosocomial Infection Treatment Market Size, 2017-2028
6.7.3 Israel Nosocomial Infection Treatment Market Size, 2017-2028
6.7.4 Saudi Arabia Nosocomial Infection Treatment Market Size, 2017-2028
6.7.5 UAE Nosocomial Infection Treatment Market Size, 2017-2028
7 Players Profiles
7.1 Abbott
7.1.1 Abbott Corporate Summary
7.1.2 Abbott Business Overview
7.1.3 Abbott Nosocomial Infection Treatment Major Product Offerings
7.1.4 Abbott Nosocomial Infection Treatment Revenue in Global Market (2017-2022)
7.1.5 Abbott Key News
7.2 Bayer
7.2.1 Bayer Corporate Summary
7.2.2 Bayer Business Overview
7.2.3 Bayer Nosocomial Infection Treatment Major Product Offerings
7.2.4 Bayer Nosocomial Infection Treatment Revenue in Global Market (2017-2022)
7.2.5 Bayer Key News
7.3 Becton, Dickinson and Company
7.3.1 Becton, Dickinson and Company Corporate Summary
7.3.2 Becton, Dickinson and Company Business Overview
7.3.3 Becton, Dickinson and Company Nosocomial Infection Treatment Major Product Offerings
7.3.4 Becton, Dickinson and Company Nosocomial Infection Treatment Revenue in Global Market (2017-2022)
7.3.5 Becton, Dickinson and Company Key News
7.4 Belimed
7.4.1 Belimed Corporate Summary
7.4.2 Belimed Business Overview
7.4.3 Belimed Nosocomial Infection Treatment Major Product Offerings
7.4.4 Belimed Nosocomial Infection Treatment Revenue in Global Market (2017-2022)
7.4.5 Belimed Key News
7.5 BioMerieux
7.5.1 BioMerieux Corporate Summary
7.5.2 BioMerieux Business Overview
7.5.3 BioMerieux Nosocomial Infection Treatment Major Product Offerings
7.5.4 BioMerieux Nosocomial Infection Treatment Revenue in Global Market (2017-2022)
7.5.5 BioMerieux Key News
7.6 Cantel
7.6.1 Cantel Corporate Summary
7.6.2 Cantel Business Overview
7.6.3 Cantel Nosocomial Infection Treatment Major Product Offerings
7.6.4 Cantel Nosocomial Infection Treatment Revenue in Global Market (2017-2022)
7.6.5 Cantel Key News
7.7 Cepheid
7.7.1 Cepheid Corporate Summary
7.7.2 Cepheid Business Overview
7.7.3 Cepheid Nosocomial Infection Treatment Major Product Offerings
7.7.4 Cepheid Nosocomial Infection Treatment Revenue in Global Market (2017-2022)
7.7.5 Cepheid Key News
7.8 Getinge Group
7.8.1 Getinge Group Corporate Summary
7.8.2 Getinge Group Business Overview
7.8.3 Getinge Group Nosocomial Infection Treatment Major Product Offerings
7.8.4 Getinge Group Nosocomial Infection Treatment Revenue in Global Market (2017-2022)
7.8.5 Getinge Group Key News
7.9 Kimberly-Clark Corp.
7.9.1 Kimberly-Clark Corp. Corporate Summary
7.9.2 Kimberly-Clark Corp. Business Overview
7.9.3 Kimberly-Clark Corp. Nosocomial Infection Treatment Major Product Offerings
7.9.4 Kimberly-Clark Corp. Nosocomial Infection Treatment Revenue in Global Market (2017-2022)
7.9.5 Kimberly-Clark Corp. Key News
7.10 Merck & Co
7.10.1 Merck & Co Corporate Summary
7.10.2 Merck & Co Business Overview
7.10.3 Merck & Co Nosocomial Infection Treatment Major Product Offerings
7.10.4 Merck & Co Nosocomial Infection Treatment Revenue in Global Market (2017-2022)
7.10.5 Merck & Co Key News
7.11 Nordion
7.11.1 Nordion Corporate Summary
7.11.2 Nordion Business Overview
7.11.3 Nordion Nosocomial Infection Treatment Major Product Offerings
7.11.4 Nordion Nosocomial Infection Treatment Revenue in Global Market (2017-2022)
7.11.5 Nordion Key News
7.12 Pfizer
7.12.1 Pfizer Corporate Summary
7.12.2 Pfizer Business Overview
7.12.3 Pfizer Nosocomial Infection Treatment Major Product Offerings
7.12.4 Pfizer Nosocomial Infection Treatment Revenue in Global Market (2017-2022)
7.12.5 Pfizer Key News
7.13 Roche
7.13.1 Roche Corporate Summary
7.13.2 Roche Business Overview
7.13.3 Roche Nosocomial Infection Treatment Major Product Offerings
7.13.4 Roche Nosocomial Infection Treatment Revenue in Global Market (2017-2022)
7.13.5 Roche Key News
7.14 Sakura Seiki
7.14.1 Sakura Seiki Corporate Summary
7.14.2 Sakura Seiki Business Overview
7.14.3 Sakura Seiki Nosocomial Infection Treatment Major Product Offerings
7.14.4 Sakura Seiki Nosocomial Infection Treatment Revenue in Global Market (2017-2022)
7.14.5 Sakura Seiki Key News
7.15 BioMérieux
7.15.1 BioMérieux Corporate Summary
7.15.2 BioMérieux Business Overview
7.15.3 BioMérieux Nosocomial Infection Treatment Major Product Offerings
7.15.4 BioMérieux Nosocomial Infection Treatment Revenue in Global Market (2017-2022)
7.15.5 BioMérieux Key News
7.16 Steris
7.16.1 Steris Corporate Summary
7.16.2 Steris Business Overview
7.16.3 Steris Nosocomial Infection Treatment Major Product Offerings
7.16.4 Steris Nosocomial Infection Treatment Revenue in Global Market (2017-2022)
7.16.5 Steris Key News
7.17 Johnson & Johnson
7.17.1 Johnson & Johnson Corporate Summary
7.17.2 Johnson & Johnson Business Overview
7.17.3 Johnson & Johnson Nosocomial Infection Treatment Major Product Offerings
7.17.4 Johnson & Johnson Nosocomial Infection Treatment Revenue in Global Market (2017-2022)
7.17.5 Johnson & Johnson Key News
7.18 Sterigenics International, Inc.
7.18.1 Sterigenics International, Inc. Corporate Summary
7.18.2 Sterigenics International, Inc. Business Overview
7.18.3 Sterigenics International, Inc. Nosocomial Infection Treatment Major Product Offerings
7.18.4 Sterigenics International, Inc. Nosocomial Infection Treatment Revenue in Global Market (2017-2022)
7.18.5 Sterigenics International, Inc. Key News
7.19 Halyard Health, Inc.
7.19.1 Halyard Health, Inc. Corporate Summary
7.19.2 Halyard Health, Inc. Business Overview
7.19.3 Halyard Health, Inc. Nosocomial Infection Treatment Major Product Offerings
7.19.4 Halyard Health, Inc. Nosocomial Infection Treatment Revenue in Global Market (2017-2022)
7.19.5 Halyard Health, Inc. Key News
7.20 Advanced Sterilization Products
7.20.1 Advanced Sterilization Products Corporate Summary
7.20.2 Advanced Sterilization Products Business Overview
7.20.3 Advanced Sterilization Products Nosocomial Infection Treatment Major Product Offerings
7.20.4 Advanced Sterilization Products Nosocomial Infection Treatment Revenue in Global Market (2017-2022)
7.20.5 Advanced Sterilization Products Key News
7.21 Matachana Group
7.21.1 Matachana Group Corporate Summary
7.21.2 Matachana Group Business Overview
7.21.3 Matachana Group Nosocomial Infection Treatment Major Product Offerings
7.21.4 Matachana Group Nosocomial Infection Treatment Revenue in Global Market (2017-2022)
7.21.5 Matachana Group Key News
8 Conclusion
9 Appendix
9.1 Note
9.2 Examples of Clients
9.3 Disclaimer
Research Methodology:
Nosocomial Infection Treatment Market Size Estimation
To estimate market size and trends, we use a combination of top-down and bottom-up methods. This allows us to evaluate the market from various perspectives—by company, region, product type, and end users.
Our estimates are based on actual sales data, excluding any discounts. Segment breakdowns and market shares are calculated using weighted averages based on usage rates and average prices. Regional insights are determined by how widely a product or service is adopted in each area.
Key companies are identified through secondary sources like industry reports and company filings. We then verify revenue estimates and other key data points through primary research, including interviews with industry experts, company executives, and decision-makers.
We take into account all relevant factors that could influence the market and validate our findings with real-world input. Our final insights combine both qualitative and quantitative data to provide a well-rounded view. Please note, these estimates do not account for unexpected changes such as inflation, economic downturns, or policy shifts.
Data Source
Secondary Sources
This study draws on a wide range of secondary sources, including press releases, annual reports, non-profit organizations, industry associations, government agencies, and customs data. We also referred to reputable databases and directories such as Bloomberg, Wind Info, Hoovers, Factiva, Trading Economics, Statista, and others. Additional references include investor presentations, company filings (e.g., SEC), economic data, and documents from regulatory and industry bodies.
These sources were used to gather technical and market-focused insights, identify key players, analyze market segmentation and classification, and track major trends and developments across industries.
Market Size |
|
|
Market Position of Top Company |
|
|
Qualitative Analysis |
|
|
Primary Sources
As part of our primary research, we interviewed a variety of stakeholders from both the supply and demand sides to gather valuable qualitative and quantitative insights.
On the supply side, we spoke with product manufacturers, competitors, industry experts, research institutions, distributors, traders, and raw material suppliers. On the demand side, we engaged with business leaders, marketing and sales heads, technology and innovation directors, supply chain executives, and end users across key organizations.
These conversations helped us better understand market segmentation, pricing, applications, leading players, supply chains, demand trends, industry outlook, and key market dynamics—including risks, opportunities, barriers, and strategic developments.
Key Data Information from Primary Sources
Primary Sources | Parameters | Key Data |
Market Segments(by Application, by Type) |
|
|
Total Market |
|
|